Kåre Berg

8.2k total citations · 1 hit paper
147 papers, 6.3k citations indexed

About

Kåre Berg is a scholar working on Surgery, Molecular Biology and Immunology. According to data from OpenAlex, Kåre Berg has authored 147 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Surgery, 31 papers in Molecular Biology and 26 papers in Immunology. Recurrent topics in Kåre Berg's work include Lipoproteins and Cardiovascular Health (49 papers), Cancer, Lipids, and Metabolism (15 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers). Kåre Berg is often cited by papers focused on Lipoproteins and Cardiovascular Health (49 papers), Cancer, Lipids, and Metabolism (15 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers). Kåre Berg collaborates with scholars based in Norway, United States and Sweden. Kåre Berg's co-authors include Gösta Dahlén, John Kjekshus, Thomas J. Cook, Anne‐Lise Børresen, Per Magnus, Kalevi Pyörälà, Anders Olsson, Ole Færgeman, Mats Frick and Richard M. Lawn and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Kåre Berg

143 papers receiving 5.9k citations

Hit Papers

A NEW SERUM TYPE SYSTEM IN MAN—THE Lp SYSTEM 1963 2026 1984 2005 1963 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kåre Berg Norway 37 3.5k 1.8k 1.3k 1.2k 808 147 6.3k
Mary Seed United Kingdom 39 2.7k 0.8× 1.7k 1.0× 987 0.8× 1.0k 0.8× 535 0.7× 116 4.6k
Jan Adolfsson Sweden 52 1.9k 0.5× 821 0.5× 1.4k 1.1× 568 0.5× 1.2k 1.4× 246 9.5k
Laurel A. Habel United States 47 2.0k 0.6× 1.4k 0.7× 2.6k 2.1× 764 0.6× 3.2k 4.0× 200 9.9k
Søren Friis Denmark 44 1.9k 0.5× 496 0.3× 1.5k 1.1× 418 0.3× 1.1k 1.3× 204 6.6k
Kevin A. Buhr United States 19 1.7k 0.5× 1.4k 0.8× 460 0.4× 740 0.6× 490 0.6× 50 3.5k
Shaker R. Dakhil United States 60 1.4k 0.4× 697 0.4× 3.1k 2.5× 618 0.5× 3.3k 4.1× 313 16.4k
Janet L. Stanford United States 59 2.9k 0.8× 882 0.5× 1.6k 1.3× 144 0.1× 2.1k 2.6× 194 12.1k
Harold E. Paulus United States 48 1.3k 0.4× 430 0.2× 281 0.2× 542 0.4× 911 1.1× 194 11.2k
Jonas Manjer Sweden 52 1.8k 0.5× 1.0k 0.6× 2.4k 1.9× 430 0.3× 2.2k 2.7× 220 8.9k
Michael W. Yeh United States 46 2.9k 0.8× 2.5k 1.4× 489 0.4× 267 0.2× 1.2k 1.4× 210 7.0k

Countries citing papers authored by Kåre Berg

Since Specialization
Citations

This map shows the geographic impact of Kåre Berg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kåre Berg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kåre Berg more than expected).

Fields of papers citing papers by Kåre Berg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kåre Berg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kåre Berg. The network helps show where Kåre Berg may publish in the future.

Co-authorship network of co-authors of Kåre Berg

This figure shows the co-authorship network connecting the top 25 collaborators of Kåre Berg. A scholar is included among the top collaborators of Kåre Berg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kåre Berg. Kåre Berg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Retterstøl, Lars, Torstein Lyberg, Trude Aspelin, & Kåre Berg. (2006). A Twin Study of Nitric Oxide Levels Measured by Serum Nitrite/Nitrate. Twin Research and Human Genetics. 9(2). 210–214. 6 indexed citations
2.
Rubin, Edward M., et al.. (2004). Human apoB contributes to increased serum total apo(a) level in LPA transgenic mice.. Lipids in Health and Disease. 3(1). 8–8. 4 indexed citations
3.
Djurovic, Srdjan, Torun Clausen, Ragnhild Wergeland, et al.. (2002). Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre‐eclampsia. BJOG An International Journal of Obstetrics & Gynaecology. 109(7). 759–764. 70 indexed citations
4.
Fossum, Eigil, Knut Erik Berge, Aud Høieggen, et al.. (2001). Polymorphisms in Candidate Genes for Blood Pressure Regulation in Young Men with Normal or Elevated Screening Blood Pressure. Blood Pressure. 10(2). 92–100. 8 indexed citations
5.
Chadwick, Ruth & Kåre Berg. (2001). Solidarity and equity: new ethical frameworks for genetic databases. Nature Reviews Genetics. 2(4). 318–321. 150 indexed citations
6.
Clausen, Torun, Srdjan Djurovic, Frank Brosstad, Kåre Berg, & Tore Henriksen. (2000). Altered circulating levels of adhesion molecules at 18 weeks’ gestation among women with eventual preeclampsia: Indicators of disturbed placentation in absence of evidence of endothelial dysfunction?. American Journal of Obstetrics and Gynecology. 182(2). 321–325. 50 indexed citations
7.
Pedersen, Terje R., Anders Olsson, Ole Færgeman, et al.. (1998). Lipoprotein Changes and Reduction in the Incidence of Major Coronary Heart Disease Events in the Scandinavian Simvastatin Survival Study (4S). Circulation. 97(15). 1453–1460. 478 indexed citations
8.
Berg, Kåre. (1997). Prenatal diagnosis in Norway.. PubMed. 5 Suppl 1. 57–60. 2 indexed citations
9.
Djurovic, Srdjan & Kåre Berg. (1997). Review: Epidemiology of Lp(a) lipoprotein: its role in atherosclerotic/thrombotic disease. Clinical Genetics. 52(5). 281–292. 54 indexed citations
10.
Pedersen, Terje R., John Kjekshus, Kåre Berg, et al.. (1996). Cholesterol Lowering and the Use of Healthcare Resources. Circulation. 93(10). 1796–1802. 137 indexed citations
11.
Berg, Kåre. (1994). Confounding results of Lp(a) lipoprotein measurements with some test kits. Clinical Genetics. 46(1). 57–62. 25 indexed citations
12.
Rødningen, Olaug K., Trond P. Leren, Oddveig Røsby, et al.. (1993). Haplotype analysis at the low density lipoprotein receptor locus in normal and familial hypercholesterolemia Norwegian subjects. Clinical Genetics. 44(4). 214–220. 15 indexed citations
13.
Berg, Kåre. (1992). Introductory Remarks: Risk Factor Levels and Variability. Annals of Medicine. 24(5). 343–347. 8 indexed citations
14.
Rødningen, Olaug K., et al.. (1992). A 9.6 kilobase deletion in the low density lipoprotein receptor gene in Norwegian familial hypercholesterolemia subjects. Clinical Genetics. 42(6). 288–295. 12 indexed citations
15.
Magnus, Per, Erik M. Magnus, & Kåre Berg. (1991). Transcobalamins in the etiology of neural tube defects. Clinical Genetics. 39(4). 309–310. 18 indexed citations
16.
Lawn, Richard M., et al.. (1991). Lipoprotein(a) and Atherosclerosis. Annals of Internal Medicine. 115(3). 209–218. 232 indexed citations
17.
Kondo, Ikuko & Kåre Berg. (1990). Inherited quantitative DNA variation in the LPA (“apolipoprotein (a)”) gene. Clinical Genetics. 37(2). 132–140. 6 indexed citations
18.
Kramer, Andrew A., Kåre Berg, & W. E. Nance. (1988). Familial aggregation of congenital dislocation of the hip in a Norwegian population. Journal of Clinical Epidemiology. 41(1). 91–96. 23 indexed citations
19.
Berg, Kåre. (1988). Variability gene effect on cholesterol at the Kidd blood group locus. Clinical Genetics. 33(2). 102–107. 32 indexed citations
20.
Berg, Kåre & Alexander G. Bearn. (1966). AN INHERITED X-LINKED SERUM SYSTEM IN MAN. The Journal of Experimental Medicine. 123(2). 379–397. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026